Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

Optimal salvage treatment for multiple myeloma relapsing after allogeneic stem cell transplantation remains to be determined. Usually, such patients have been heavily pre-treated and present at relapse with a relatively refractory disease. Immunomodulatory properties of lenalidomide may be beneficia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Coman, Tereza, Bachy, Emmanuel, Michallet, Mauricette, Socié, Gérard, Uzunov, Madalina, Bourhis, Jean Henri, Lapusan, Simona, Brebion, Alain, Vigouroux, Stéphane, Maury, Sébastien, François, Sylvie, Huynh, Anne, Lioure, Bruno, Yakoub-Agha, Ibrahim, Hermine, Olivier, Milpied, Noël, Mohty, Mohamad, Rubio, Marie Thérèse
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640124/
https://ncbi.nlm.nih.gov/pubmed/23144198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.069328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados